8-K: Semler Scientific Announces Preliminary Q1 2025 Results, Bitcoin Holdings, and Coinbase Loan Agreement

Semler Scientific reports preliminary Q1 2025 results including revenue, loss from operations, unrealized loss from Bitcoin holdings, and a contingent liability related to a DOJ settlement, while also entering into a loan agreement with Coinbase.

Summary

• Semler Scientific has released preliminary unaudited financial information for the first quarter ended March 31, 2025.
• The company anticipates revenues between $8.8 and $8.9 million.
• They expect a loss from operations between $1.3 and $1.5 million, which includes non-cash stock compensation, state sales and use tax accrual, and legal fees related to a DOJ civil investigative demand.
• Semler Scientific reports an unrealized loss of approximately $41.8 million from the change in fair value of its Bitcoin holdings since December 31, 2024.
• As of March 31, 2025, the company held 3,192 Bitcoins, valued at approximately $263.5 million.
• A contingent liability of approximately $29.75 million is related to the settlement of a DOJ CID.
• The company's cash, restricted cash, and cash equivalents as of March 31, 2025, were approximately $9.9 million.
• Semler Scientific has reached an agreement in principle with the DOJ to settle all claims for $29.75 million.
• The company entered into a Master Loan Agreement with Coinbase Credit Inc. on April 15, 2025, to potentially borrow cash or digital assets collateralized by Bitcoin.
• Semler Scientific intends to borrow under the Coinbase agreement to pay the proposed settlement with the DOJ.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the loss from operations, unrealized loss on Bitcoin holdings, and the contingent liability related to the DOJ settlement. The Coinbase loan agreement provides some financial flexibility, but also introduces additional risks.

Positives

• Semler Scientific is actively working to resolve the DOJ CID with a proposed settlement.
• The company has secured a potential funding source through the Coinbase Master Loan Agreement.
• Semler Scientific holds a significant amount of Bitcoin, valued at $263.5 million as of March 31, 2025.

Negatives

• The company anticipates a loss from operations of $1.3 to $1.5 million for Q1 2025.
• Semler Scientific faces an unrealized loss of $41.8 million from the change in fair value of its Bitcoin holdings.
• A contingent liability of $29.75 million is related to the settlement of a DOJ CID.
• The company's cash position is relatively low at $9.9 million as of March 31, 2025.

Risks

• The preliminary financial information is unaudited and subject to change.
• There is no guarantee that Semler Scientific will reach a final settlement agreement with the DOJ or HHS.
• If a final settlement is not reached, the DOJ may file a lawsuit seeking damages in excess of the agreed settlement amount.
• Borrowing under the Coinbase agreement is subject to risks related to changing interest rates, credit markets, and Bitcoin volatility.
• The value of Bitcoin collateralizing the loan could fall below minimum margin requirements, requiring the company to transfer additional Bitcoin or repay the loan.
• The company's Bitcoin treasury strategy is subject to risks related to the volatility of Bitcoin.

Future Outlook

The company's future performance is subject to risks and uncertainties related to the financial close process, settlement with the DOJ, borrowing funds, and the volatility of Bitcoin. Semler Scientific assumes no obligation to update or revise forward-looking statements unless required by law.

Industry Context

Semler Scientific's investment in Bitcoin reflects a growing trend of companies diversifying their treasury reserves with digital assets. The company's agreement with Coinbase is part of a broader trend of companies using crypto-backed loans to manage liquidity and fund operations. The DOJ investigation and settlement are relevant to the healthcare industry, where regulatory scrutiny and compliance are significant concerns.

Comparison to Industry Standards

• It is difficult to compare Semler Scientific's Bitcoin strategy to industry standards as it is not a common practice.
• Other companies that have invested in Bitcoin include MicroStrategy and Tesla, but their strategies and financial situations differ significantly.
• The contingent liability related to the DOJ CID is a significant event that could impact the company's financial performance and reputation.
• The loan agreement with Coinbase is a relatively new type of financing arrangement, and its success will depend on the company's ability to manage its Bitcoin collateral and repay the loan.

Legal Proceedings

• Semler Scientific is in settlement discussions with the DOJ regarding a civil investigative demand.
• The company has reached an agreement in principle to pay $29.75 million to settle all claims.
• There is a risk that the DOJ will file a complaint if a final settlement is not reached.

Stakeholder Impact

• Shareholders face potential dilution if the company issues equity to raise capital.
• Employees may be affected by cost-cutting measures implemented to address financial challenges.
• Customers may be impacted by changes in the company's products or services.
• Suppliers and creditors may be affected by the company's financial performance and ability to meet its obligations.

Next Steps

• Finalize the settlement agreement with the DOJ and HHS.
• Borrow funds under the Coinbase Master Loan Agreement.
• Complete the financial closing procedures for the first quarter ended March 31, 2025.
• Monitor the value of Bitcoin collateralizing the Coinbase loan.

Key Dates

Keywords

Semler Scientific, Bitcoin, Coinbase, DOJ, Settlement, Loan Agreement, Q1 2025, Financial Results, Unaudited, Revenue, Loss, Holdings